Managed Account Advisors’s Gilead Sciences GILD Stock Holding History

Managed Account Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$313M	Buy	2,673,456 +84,998	+3%	+$9.29M	0.26%	104
2015 Q1	$254M	Sell	2,588,458 -237,368	-8%	-$24.1M	0.22%	123
2014 Q4	$266M	Sell	2,825,826 -1,370,124	-33%	-$142M	0.26%	100
2014 Q3	$447M	Sell	4,195,950 -499,014	-11%	-$48.9M	0.5%	31
2014 Q2	$389M	Sell	4,694,964 -552,880	-11%	-$43M	0.47%	35
2014 Q1	$372M	Sell	5,247,844 -101,629	-2%	-$7.97M	0.48%	32
2013 Q4	$402M	Buy	5,349,473 +21,989	+0.4%	+$1.53M	0.54%	26
2013 Q3	$335M	Sell	5,327,484 -221,358	-4%	-$13.2M	0.49%	31
2013 Q2	$284M	Buy	+5,548,842	New	+$289M	0.44%	38

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Managed Account Advisors's GILD Position: Q2 2015 in Review

Managed Account Advisors increased its Gilead Sciences (GILD) stake by 3.3% in Q2 2015, buying an estimated $9.29M and bringing the position to 2,673,456 shares worth $313M. The position accounts for 0.26% of the portfolio, ranked #104.

Managed Account Advisors first reported a position in GILD in Q2 2013 and has held it in 9 quarters since. The position peaked at $447M in Q3 2014. 1,561 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

Managed Account Advisors held 2,673,456 shares of Gilead Sciences worth $313M as of Q2 2015.
Managed Account Advisors bought 84,998 Gilead Sciences shares in Q2 2015, an estimated $9.29M.
Gilead Sciences made up 0.26% of Managed Account Advisors's portfolio in Q2 2015, its #104 holding.
Managed Account Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Gilead Sciences position peaked at $447M in Q3 2014.
1,561 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.